Quick Answer
KIORA PHARMACEUTICALS INC reported Research And Development Expense of $10.78 million for the year ending 2025.
- KIORA PHARMACEUTICALS INC showed an increase of +37.5% in Research And Development Expense from 2024 to 2025.
- This data is from KIORA PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 12 years of available data (2014 to 2025), KIORA PHARMACEUTICALS INC's Research And Development Expense has grown by 1,929.8%.
- Historical annual values: Fiscal year 2025: $10.78 million | Fiscal year 2024: $7.84 million | Fiscal year 2023: $4.03 million | Fiscal year 2022: $3.45 million | Fiscal year 2021: $5.35 million | Fiscal year 2020: $3.57 million | Fiscal year 2019: $5.39 million | Fiscal year 2018: $8.06 million | Fiscal year 2017: $10.33 million | Fiscal year 2016: $8.42 million | Fiscal year 2015: $2.72 million | Fiscal year 2014: $531.1 thousand.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: